We are live on ! Find out more
TLSI icon

TriSalus Life Sciences
TLSI

68 hedge funds and large institutions have $219M invested in TriSalus Life Sciences in 2022 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 12

15% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 13

10% more capital invested

Capital invested by funds: $198M → $219M (+$20.5M)

8.78% more ownership

Funds ownership: 80.46% → 89.24% (+8.8%)

0% more funds holding

Funds holding: 68 → 68 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
68
Holders Change
–
Holders Change %
0%
% of All Funds
1.07%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
15
Increased
20
Reduced
12
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
KC
Kryger Capital
United Kingdom
+$7.45M
2
Verition Fund Management
Verition Fund Management
Connecticut
+$5.28M
3
AC
Antara Capital
New York
+$4.93M
4
Millennium Management
Millennium Management
New York
+$4.85M
5
IPCP
Iron Park Capital Partners
New York
+$4.27M

Top Sellers

Rank Fund Capital Flow
1
AC
Aristeia Capital
Connecticut
-$11.4M
2
WRBC
W.R. Berkley Corp
Connecticut
-$2.9M
3
Citadel Advisors
Citadel Advisors
Florida
-$2.39M
4
PMAM
Picton Mahoney Asset Management
Ontario, Canada
-$2.22M
5
AGC
Angelo Gordon & Co
New York
-$1.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
CH
26
CVI Holdings
Delaware
$2.94M +$49.9K +5,057 +2%
SV
27
Starboard Value
New York
$2.92M – – –
BCL
28
Bracebridge Capital LLC
Massachusetts
$2.91M +$2.93M +296,572 New
Balyasny Asset Management
29
Balyasny Asset Management
Illinois
$2.81M – – –
VI
30
Vestcor Inc
New Brunswick, Canada
$2.71M – – –
DFCM
31
Dark Forest Capital Management
Puerto Rico
$2.53M +$2.54M +257,359 +42,893%
BCM
32
Basso Capital Management
Connecticut
$2.45M +$2.47M +250,021 New
Point72 Asset Management
33
Point72 Asset Management
Connecticut
$1.96M – – –
D.E. Shaw & Co
34
D.E. Shaw & Co
New York
$1.89M +$734K +74,339 +63%
SIA
35
SkyView Investment Advisors
New Jersey
$1.47M +$1.48M +150,000 New
KIM
36
Karpus Investment Management
New York
$1.28M +$1.29M +131,000 New
FTCM
37
Fir Tree Capital Management
New York
$1.23M – – –
PC
38
Periscope Capital
Ontario, Canada
$980K -$62.9K -6,371 -6%
LCM
39
Landscape Capital Management
New Jersey
$973K -$148K -14,958 -13%
AA
40
AQR Arbitrage
Connecticut
$840K -$360K -36,513 -30%
Blackstone Inc
41
Blackstone Inc
New York
$755K +$760K +77,005 New
CM
42
Crestline Management
Texas
$607K +$79.9K +8,100 +15%
CC
43
Centiva Capital
New York
$523K +$527K +53,364 New
WA
44
Whitebox Advisors
Minnesota
$516K – – –
WRBC
45
W.R. Berkley Corp
Connecticut
$514K -$2.9M -293,708 -85%
TIM
46
Timelo Investment Management
Ontario, Canada
$490K – – –
CM
47
Cohanzick Management
New York
$490K +$493K +50,000 New
COPPSERS
48
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$394K -$96.7K -9,800 -20%
OCAM
49
Owl Creek Asset Management
New York
$392K – – –
E
50
Ergoteles
New York
$382K +$384K +38,940 New
1
2
3 4

TLSI Hedge Fund Activity: Q1 2022 in Review

68 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences (TLSI) for Q1 2022, worth a combined $219M — up 10% from $198M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new TLSI positions and 13 closed out — a net gain of 2 holders — while 20 added to existing stakes and 12 trimmed.

The largest buyer was Kryger Capital, adding an estimated $7.45M. The largest seller was Aristeia Capital, exiting entirely with an estimated $11.4M sold.

  • 68 institutional investors held TriSalus Life Sciences (TLSI) as of Q1 2022, unchanged from Q4 2021.
  • Funds reported $219M of TriSalus Life Sciences stock for Q1 2022, up 10% quarter-over-quarter.
  • 15 funds opened new TriSalus Life Sciences positions in Q1 2022 and 13 closed out, a net change of +2 holders.
  • The largest TriSalus Life Sciences buyer in Q1 2022 was Kryger Capital, an estimated $7.45M added.
  • The largest TriSalus Life Sciences seller in Q1 2022 was Aristeia Capital, an estimated $11.4M sold.

Based on aggregated 13F filings for Q1 2022.